Zydus Lifesciences Limited, formerly known as Cadila Healthcare, is a global life sciences company dedicated to discovering, developing, manufacturing, and marketing innovative healthcare solutions. Founded in 1952, the company has built a diversified portfolio spanning prescription medicines, vaccines, biologics, biosimilars, consumer wellness products, and active pharmaceutical ingredients. Zydus operates across more than 50 countries and has established strong capabilities in cardiovascular, oncology, gastroenterology, vaccines, nephrology, and women’s healthcare. The company is recognized for its significant investments in research and development, including novel chemical entities, biologics, and vaccine innovation. Its manufacturing facilities comply with leading international regulatory requirements, enabling broad access to global markets. Through scientific innovation, strategic collaborations, and a commitment to affordable healthcare, Zydus continues to strengthen its global footprint. The company remains focused on addressing unmet medical needs while advancing patient outcomes through high-quality pharmaceutical and biotechnology products.
NSE: ZYDUSLIFE | BSE: 532321
Ahmedabad, Gujarat, India
~27,000 employees
